Patient attrition in Molecular Tumour Boards: a systematic review.
Hannah FrostDonna M GrahamLouise CarterPaul O'ReganDónal LandersAndré FreitasPublished in: British journal of cancer (2022)
As patient attrition in MTBs is an issue which is very rarely alluded to in reporting, more transparent reporting is needed to understand barriers to treatment and integration of new technologies is required to process increasing omic and treatment data.